Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

DCGI Approval for Bedaquiline


Published on

The Form 45 conditional approval granted by the Drug Controller General of India to Johnson & Johnson for the bedaquiline, intended to treat drug-resistant tuberculosis (DR-TB)

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this